Personalizing Financial Incentives (Log2LoseAI)

March 5, 2026 updated by: Corrine Voils, University of Utah

Log2LoseAI: Reinforcement Learning to Create a Framework for Personalizing Financial Incentives

The purpose of this study is to determine the feasibility of providing personalized incentives for dietary self-monitoring and/or interim weight loss to people enrolled in a weight-loss program

Study Overview

Status

Recruiting

Detailed Description

In this study, community outpatients will participate in a clinician-facilitated, group-based behavioral weight-loss program for 24 weeks. Dietary self-monitoring data (input by patients via a mobile phone dietary application) and weight data (input by patients via cellular scale) will be collected by a software platform. A reinforcement learning algorithm will use data collected during the trial to predict which participants will respond to a financial incentive. Incentives will be provided to participants predicted to respond, and they will be notified of incentives via text messaging.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Willing to attend virtual baseline and follow-up data collection visits
  2. At least 18 years of age
  3. Verified obesity as defined as a BMI ≥30 kg/m2
  4. Agree to attend 13 biweekly group classes (virtual) delivered by a registered dietitian
  5. Agree to review study materials between classes
  6. Regular access to an unshared smart phone
  7. Reliable access to internet
  8. Able to speak and read English
  9. Desire to lose weight
  10. Able to connect to a video conference call using a smartphone, tablet or computer with a webcam and microphone
  11. Ability to download and use Fitbit app daily
  12. Have or be willing to create a Gmail address
  13. Physical ability to stand on a scale without support

Exclusion Criteria:

  1. Weight loss of at least 10lbs in the month prior to screening
  2. Weight > 380lbs
  3. Currently enrolled or enrolled in the previous month in a clinical, research, or community program focusing on lifestyle change that could affect weight
  4. New user of weight loss medication
  5. Pregnant, lactating or planning on becoming pregnant during the study
  6. History of bariatric procedure or planning to have bariatric procedure in the study timeframe
  7. Residing in a nursing home, skilled nursing facility or assisted living facility
  8. Impaired hearing
  9. Significant dementia, drug or alcohol abuse, or unstable psychiatric illness (e.g., schizophrenia, psychosis)
  10. Current treatment for cancer or being treated for cancer (besides basal cell carcinoma or squamous cell) in the last 6 months
  11. Use of insulin, sulfonylureas, or meglitinides due to increased risk for hypoglycemia
  12. Diuretic medication doses higher than hydrochlorothiazide or chlorthalidone 25 mg daily, furosemide 40 mg daily, torsemide 20 mg daily, bumetanide 1 mg daily, or any use of metolazone; use of potassium-sparing diuretics is acceptable
  13. Unstable heart disease in the 6 months prior to screening
  14. Chronic kidney disease at stage 4 or higher
  15. Exertional chest pain
  16. Pain, fainting, or other conditions that prohibit mild/moderate exercise
  17. History of ascites requiring paracentesis
  18. Inducing vomiting to prevent weight gain or counteract the effects of eating an average of 1 time per week or more in the past 3 months*
  19. Not suitable for study participation due to other reasons at the discretion of the investigators

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Personalized incentives
Participants may receive financial incentives for weight loss if their performance suggests they respond to financial incentives.
Every week, a reinforcement learning algorithm will process data on weight loss, calorie logging, and incentives earned to predict that their weight loss is positively influenced by incentives.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Screening-to-enrollment ratio
Time Frame: Week 0
number of potential participants screened for the study/ number of participants who provide a baseline weight for the intervention
Week 0
Retention for outcomes
Time Frame: 25 weeks
number of participants who provide a weight at 25 weeks/number of participants who provide a baseline weight for the intervention
25 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to calorie logging
Time Frame: 24 weeks
Proportion of weeks participants achieve adequate calorie logging (5 days per week)
24 weeks
Adherence to self-weighing
Time Frame: 24 weeks
Proportion of weeks participants weigh at least twice per week on a study-provided cellular scale
24 weeks
Body weight
Time Frame: baseline to 25 weeks
Changes in body weight from baseline to week 25, measured by study-provided cellular scales
baseline to 25 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2026

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

February 28, 2027

Study Registration Dates

First Submitted

November 4, 2025

First Submitted That Met QC Criteria

November 5, 2025

First Posted (Actual)

November 6, 2025

Study Record Updates

Last Update Posted (Actual)

March 6, 2026

Last Update Submitted That Met QC Criteria

March 5, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

This study will collect weight data from the cellular-connect scales, calorie logging data from the dietary tracking app, and self-reported survey data including demographics and behavioral measures. Additional data will include binary indicators for whether participants earned an incentive each week of the study and how much they earned, generated by algorithms created by the research team using scale and dietary tracking app data.

IPD Sharing Time Frame

Scientific data will be available by the earlier of these two time points, as required by the NIH: 1) the date on which the article is first made available in print or electronic format, or 2) the funding period (to include a possible no-cost extension).

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity & Overweight

Clinical Trials on personalized financial incentives

Subscribe